Thrombolysis in Acute Myocardial Infarction
- 2 September 1993
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 329 (10), 703-709
- https://doi.org/10.1056/nejm199309023291006
Abstract
Acute myocardial infarction is the most common cause of death in the United States and in almost all Western industrialized countries. Although unadjusted rates of mortality due to myocardial infarction in the United States have been falling in recent years, rates of mortality from all other causes have also been falling, so that the proportion of mortality caused by acute myocardial infarction has not changed. Mortality due to heart disease (mostly infarctions) accounted for 37 percent of all deaths for which a cause could be identified in 1950, for 39 percent in 1960, 1970, and 1980, and for 36 percent . . .Keywords
This publication has 46 references indexed in Scilit:
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Patency of the infarct-related artery and left ventricular function as the major determinants of survival after Q-wave acute myocardial infarctionThe American Journal of Cardiology, 1993
- Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: A risk-benefit analysisThe American Journal of Cardiology, 1992
- Clinical risks of thrombolytic therapyThe American Journal of Cardiology, 1992
- Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarctionThe American Journal of Cardiology, 1990
- Optimal utilization of thrombolytic therapy for acute myocardial infarction: Concepts and controversiesJournal of the American College of Cardiology, 1990
- Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1989
- Improved survival up to four years after early coronary thrombolysisThe American Journal of Cardiology, 1988
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart DiseaseNew England Journal of Medicine, 1981